Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism A2aR antagonists(Adenosine A2a receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | IND Application | IN | 30 Jan 2022 | |
Parkinson Disease | Preclinical | IN | 27 Jun 2020 | |
Cognition Disorders | Preclinical | IN | 30 May 2020 | |
Breast Cancer | Preclinical | IN | 18 May 2020 | |
Colorectal Cancer | Preclinical | IN | 16 May 2020 |